Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Stalevo

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
The results of the large-scale study STRIDE-PD of patients with Parkinson's disease (PD) are presented. The aim of the study was… Expand
Is this relevant?
2012
2012
Levodopa remains a 'gold standard' for the treatment of patients with Parkinson's disease (PD), but its chronic use is… Expand
Is this relevant?
2011
2011
All patients with Parkinson's disease (PD) with motor fluctuations due to long-term levodopa therapy have at least one non-motor… Expand
Is this relevant?
2011
2011
Nocturnal symptoms are integral part of the general clinical picture of Parkinson's disease (PD). They are subdivided into non… Expand
Is this relevant?
2009
2009
The triple combination of levodopa, DDCI and entacapone (Stalevo) is used to treat motor complication in patients with Parkinson… Expand
Is this relevant?
2008
2008
The addition of entacapone to levodopa-carbidopa (LC) or the switch from LC to a tablet containing levodopa-carbidopa-entacapone… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2008
2008
An open randomized study of pharmacoeconomic efficacy of stalevo in patients with Parkinson's disease with motor fluctuations was… Expand
Is this relevant?
2006
2006
OBJECTIVES AND METHODS This study investigated the ease with which 52 Parkinson's disease patients already receiving adjunct… Expand
Is this relevant?
2006
2006
Based on literature data on the usage of Dopa medications in the treatment of Parkinson's disease (PD), a characteristic of a new… Expand
Is this relevant?
2005
2005
The aim of this study was to evaluate the efficacy of the new optimised levodopa, Stalevo® (levodopa, carbidopa and entacapone… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?